Carenoprazan hydrochloride by Jiangsu Carephar Pha..

created a new article

1 y - Translate

Carenoprazan hydrochloride by Jiangsu Carephar Pharmaceutical for Peptic Ulcers: Likelihood of Approval | #peptic Ulcers Pipeline Drugs Market

Carenoprazan hydrochloride by Jiangsu Carephar Pharmaceutical for Peptic Ulcers: Likelihood of Approval

Carenoprazan hydrochloride by Jiangsu Carephar Pharmaceutical for Peptic Ulcers: Likelihood of Approval

Peptic ulcer drugs in Phase I have a 77% phase transition success rate (PTSR) indication benchmark for progressing into Phase II, as stated by GlobalData. Carenoprazan hydrochloride's drug-specific PTSR and Likelihood of Approval (LoA) scores are compared to indication benchmarks in

Like

Comment

Share